This grant is intended to fund ambitious research programs that offer the potential for large benefits to society. Multidisciplinary teams will conduct research that will keep Canada in the vanguard of nanomedicine technology development.

The Leslie Lab is excited to announce that we are joining a talented team of scientists who have been awarded $1,500,000 collectively to collaborate on research which is focused on the development, optimization, and evaluation of novel nanoparticle formulations for extra-hepatic targeted gene therapy. This will be led Drs. Blakney, Cullis, Leslie, Foster, Harder, Ross, and Bertrand.

More information can be found here